Trapp Larry, Will John
Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350, USA.
Dent Clin North Am. 2010 Oct;54(4):665-75. doi: 10.1016/j.cden.2010.06.007. Epub 2010 Aug 7.
Dentistry has two medications in its pain management armamentarium that may cause the potentially life-threatening disorder methemoglobinemia. The first medications are the topical local anesthetics benzocaine and prilocaine. The second medication is the injectable local anesthetic prilocaine. Acquired methemoglobinemia remains a source of morbidity and mortality in dental and medical patients despite the fact that it is better understood now than it was even a decade ago. It is in the interest of all dental patients that their treating dentists review this disorder. The safety of dental patients mandates professional awareness.
牙科在其疼痛管理手段中有两种药物可能会导致具有潜在生命危险的高铁血红蛋白血症。第一种药物是局部外用麻醉剂苯佐卡因和丙胺卡因。第二种药物是注射用局部麻醉剂丙胺卡因。尽管与十年前相比,现在对后天性高铁血红蛋白血症的了解更深入了,但它仍是牙科和医疗患者发病和死亡的一个原因。为了所有牙科患者的利益,他们的主治牙医应复查这种病症。牙科患者的安全要求专业人员提高认识。